INMD - InMode's Quest For Growth Amidst Aesthetic Adversities

2024-04-02 21:34:12 ET

Summary

• InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges.
• High dependence on U.S. revenue from minimally invasive procedures; facing increasing competition in RF technology.
• R&D spending at 3% of revenue, below industry norm; sales and marketing costs rising.
• Investment stance: Hold, pending revenue diversification and increased R&D investment focus.

InMode's Rocky Ride: Unpacking a Bumpy Quarter

InMode's ( INMD ) stock is off 7% since my initial look back in November. At the same time, the SP500 has returned 15%. My last analysis focused on the company's prospects in a high interest rate and competitive landscape. Since then, InMode revealed Q4 earnings. The following article will focus on the intricacies of those numbers and what they may be signaling about InMode. ...

For further details see: